Adrienne Watson Email & Phone Number

Sarasota, Fl, Us

Innovating biomedical research through advanced instrumentation and applications.

• Created novel gene editing platform for in vivo production of 6 genetically induced brain tumor models resulting in foundational IP.• Accessed 10 neuro-oncology assets for therapeutic development through co-development and licensing deals with asset owners valued at over $100MM. • Assembled and ran a multidisciplinary Strategic Advisory Board of 6 world renowned neuro-oncology KOLs gaining objective input on business-critical decisions.• Developed a $45MM, 5-year financial and strategic growth plan with milestones, deliverables, and strategy for funding with multiple paths to exit.

Eagan, Minnesota, Us

• Drove investor outreach for subsidiary spin-out • Managed supply chain challenges through improving operational efficiencies by >50% and allowing for budget to fund increases in production and FTE’s for staffing.• Directed 16,0000 sq ft. USDA licensed swine facility to support >20 approved IACUC's for animal research and providing animals for >30 internal and >15 external research projects with academic centers of excellence, pharmaceutical and medical device companies.

Eagan, Minnesota, Us

• Developed the world's first swine model and market standard of Neurofibromatosis Type 1 & 2 through securing a combined $2.36M in grant funding.• Applied genomic engineering to establish, characterize and validate 15 biomedical swine models, 12 regenerative medicine models, and 6 agricultural traits in cattle and swine.

Eagan, Minnesota, Us

• Developed the enabling data for foundational IP at Recombinetics, resulting in 62 issued patents and 182 pending patents worldwide.

Minneapolis And St. Paul, Minnesota, Us

• Provided novel platform validation data to identify tumor-associated antigens in a variety of cancer types.

Minneapolis And St. Paul, Minnesota, Us

Laboratory of Dr. David LargaespadaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455Project 1: A Sleeping Beauty forward genetic screen to identify genes involved in the development and progression of malignant peripheral nerve sheath tumorsProject 2: Novel drug targeting in Neurofibromatosis Type I and malignant peripheral nerve sheath tumors

Minneapolis And St. Paul, Minnesota, Us

Laboratory of Dr. Scott SelleckDevelopmental Biology Center, University of Minnesota, Minneapolis, MN 55455Project: Electrophysiological analysis of the Drosophila neuromuscular junction, the role of mTor signaling in Drosophila axon guidance, analysis of heparan sulfate proteoglycan sulfation patterns in Hurler’s syndrome, the importance of proteoglycan sulfation patterns in vascular development and angiogenesis.

Minneapolis And St. Paul, Minnesota, Us

Laboratory of Dr. Scott SelleckDevelopmental Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455Project: Axon guidance in the Drosophila nervous system, the PI3k/mTOR/Akt pathway control growth and patterning in the Drosophila visual system, the effect of dietary intake on Drosophila behavior and neural development.

Minneapolis And St. Paul, Minnesota, Us

Laboratory of Dr. Susan BerryInstitute of Human Genetics, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455Project: Transcriptional control of growth hormone regulated genes in the mammalian liver.

Doctor Of Philosophy (Ph.D.), Molecular, Cellular, Developmental Biology And Genetics

Bachelor Of Science (B.S.), Genetics, Cell Biology And Development

B.S. Minor, Chemistry